Septic Arthritis

Septic arthritis, also known as infectious arthritis or suppurative arthritis, is a severe, rapidly progressive inflammatory joint disease caused by the invasion and proliferation of pathogenic microorganisms within the synovial cavity. This condition is a surgical emergency in veterinary medicine, as the combination of bacterial toxins, host inflammatory response, and proteolytic enzymes can lead to irreversible destruction of articular cartilage, synovial membrane damage, and eventual degenerative joint disease or ankylosis. Septic arthritis can affect any diarthrodial joint, but is most commonly seen in the stifle, elbow, hip, and tarsus in dogs and cats. The disease is classified based on the route of infection: hematogenous (bacterial spread from a distant site), direct inoculation (trauma, surgery, or injection), or contiguous spread from adjacent osteomyelitis or soft tissue infection. In veterinary surgical practice, septic arthritis is a critical diagnosis that requires immediate, aggressive intervention, including joint lavage, debridement, and appropriate antimicrobial therapy, to preserve joint function and prevent systemic sepsis.

The primary causative agents of septic arthritis are bacteria, with Staphylococcus spp. (particularly S. pseudintermedius and S. aureus), Streptococcus spp., Escherichia coli, Pasteurella multocida, and anaerobes such as Bacteroides and Fusobacterium being most commonly isolated. In dogs, hematogenous spread from skin, urinary tract, or respiratory infections is common, while in cats, bite wounds are a frequent source of direct inoculation. Iatrogenic causes include contaminated joint injections, arthrocentesis, or surgical procedures. Fungal infections (e.g., Blastomyces, Coccidioides) and mycoplasma (e.g., Mycoplasma gateae in cats) are less common but should be considered in endemic areas or in immunocompromised patients. The anatomical vulnerability of joints lies in the synovial membrane's high vascularity and lack of a basement membrane, which facilitates bacterial seeding. Biomechanical triggers include trauma that disrupts the joint capsule, allowing direct bacterial entry. Cellular mechanisms involve bacterial adhesion to synovial cells and cartilage matrix, followed by release of toxins and enzymes that trigger an intense inflammatory response.

Septic arthritis is relatively uncommon in dogs and cats, accounting for less than 1% of all joint diseases, but it is a significant cause of morbidity. Large-breed dogs, particularly those with high activity levels, are overrepresented, likely due to increased risk of trauma. German Shepherd Dogs, Labrador Retrievers, and Rottweilers are commonly affected. Young, intact male dogs are at higher risk, possibly due to fighting and roaming behaviors. In cats, no strong breed predilection exists, but outdoor cats with bite wounds are at increased risk. Age distribution is bimodal: young animals (less than 2 years) often develop hematogenous septic arthritis, while older animals may develop it secondary to degenerative joint disease or immunosuppression. Working dogs, such as police and military dogs, have a higher incidence due to trauma. The incidence of iatrogenic septic arthritis is estimated at 1-5% following joint surgery, with higher rates after procedures involving implants.

The pathophysiology of septic arthritis is a cascade of events initiated by bacterial colonization of the synovium. Bacteria adhere to synovial cells and cartilage via adhesins and biofilm formation. The host immune response involves recruitment of neutrophils, which release proteolytic enzymes (e.g., matrix metalloproteinases, elastase) and reactive oxygen species, leading to degradation of articular cartilage proteoglycans and collagen. Bacterial toxins, such as staphylococcal enterotoxins and streptococcal pyrogenic exotoxins, act as superantigens, causing massive T-cell activation and cytokine release (TNF-α, IL-1, IL-6), amplifying the inflammatory response. Synovial hyperplasia and pannus formation occur, further damaging cartilage. Increased intra-articular pressure from effusion compromises synovial blood flow, leading to ischemia and necrosis of the synovium and subchondral bone. If untreated, the inflammatory process extends to the periarticular soft tissues, causing cellulitis and abscess formation. Systemic inflammatory response syndrome (SIRS) can develop, leading to fever, leukocytosis, and potentially sepsis and multi-organ dysfunction. Chronic infection can result in fibrous ankylosis or osseous fusion of the joint.

Intrinsic risk factors include conformational abnormalities (e.g., joint laxity, angular limb deformities) that predispose to trauma or abnormal wear. Genetic factors, such as immunodeficiencies (e.g., IgA deficiency in certain breeds), increase susceptibility to infection. Metabolic diseases like diabetes mellitus or hyperadrenocorticism impair immune function. Age and weight are significant: young animals have immature immune systems, while obese animals have increased joint stress and may have impaired wound healing. Extrinsic factors include trauma (bite wounds, penetrating injuries, fractures involving the joint), prior joint surgery (especially with implants), intra-articular injections (corticosteroids, hyaluronan), and environmental exposure to pathogens. Poor nutrition, poor hygiene, and overcrowding in kennels or shelters increase infection risk. Excessive activity or overuse can cause microtrauma to joints, facilitating bacterial seeding. Prior antibiotic therapy may select for resistant organisms.

Clinical signs of septic arthritis are typically acute and severe. Lameness is the most prominent sign, ranging from non-weight-bearing to severe weight-bearing lameness, often with a sudden onset. The affected joint is swollen, warm to the touch, and painful on palpation and manipulation. Joint effusion is common, and the joint may be held in a flexed position to relieve pain. Crepitus may be present if cartilage damage is advanced. Systemic signs include fever (often >103.5°F), lethargy, anorexia, and depression. In severe cases, signs of sepsis (tachycardia, tachypnea, pale mucous membranes, prolonged capillary refill time) may be present. On orthopedic examination, the animal may resent any movement of the joint, and regional lymph nodes may be enlarged. In chronic cases, muscle atrophy and decreased range of motion may be noted. Neurological deficits are rare unless the infection spreads to the spinal cord or peripheral nerves.

Differential diagnoses for septic arthritis include: 1) Immune-mediated polyarthritis (IMPA) - typically affects multiple joints, is non-erosive, and responds to immunosuppressive therapy; synovial fluid culture is negative. 2) Degenerative joint disease (osteoarthritis) - chronic, progressive lameness with radiographic evidence of osteophytes and subchondral sclerosis, but no systemic signs or joint effusion with septic characteristics. 3) Trauma (sprain, strain, fracture) - history of injury, radiographic evidence of fracture or soft tissue swelling, but joint fluid is non-septic. 4) Rheumatoid arthritis - rare in dogs, erosive, with positive rheumatoid factor. 5) Lyme disease (borreliosis) - causes polyarthritis, positive serology, and history of tick exposure. 6) Fungal arthritis (e.g., blastomycosis) - endemic areas, granulomatous inflammation on cytology, and fungal culture. 7) Neoplasia (synovial cell sarcoma) - chronic lameness, radiographic bone lysis, and cytology/histopathology showing neoplastic cells. 8) Gout (rare in dogs) - urate crystals in joint fluid. 9) Hemarthrosis (coagulopathy, trauma) - sanguineous joint fluid with no inflammatory cells. 10) Panosteitis - affects long bones, not joints, with characteristic radiographic changes.

The diagnostic algorithm for septic arthritis begins with a thorough history and physical examination, focusing on lameness and joint swelling. Orthopedic examination should include palpation of all joints, assessment of range of motion, and pain response. If septic arthritis is suspected, arthrocentesis is the next step: the joint is clipped and aseptically prepared, and synovial fluid is collected for analysis (cell count, cytology, culture and sensitivity, and mucin clot test). Synovial fluid should be placed in an EDTA tube for cell count and cytology, and in a sterile tube for culture. Blood cultures are recommended if hematogenous spread is suspected. Complete blood count (CBC), serum biochemistry, and urinalysis are performed to assess systemic health and identify a primary infection source. Imaging is essential: radiographs of the affected joint may show soft tissue swelling, joint effusion, and in chronic cases, periarticular osteophytes, subchondral bone lysis, or joint space widening. Advanced imaging (CT or MRI) is indicated if osteomyelitis or deep soft tissue infection is suspected. Arthroscopy can be both diagnostic and therapeutic, allowing direct visualization of synovial inflammation and cartilage damage, and collection of tissue samples for culture and histopathology. If the diagnosis remains uncertain, exploratory arthrotomy may be performed.

Synovial fluid analysis is the cornerstone of diagnosis. Normal synovial fluid is clear, viscous, and has a mucin clot quality of good to excellent. In septic arthritis, the fluid is typically turbid, watery, and may be sanguineous. The mucin clot is poor. Total nucleated cell count (TNCC) is markedly elevated, often >50,000 cells/μL (normal <3,000 cells/μL), with >90% neutrophils, many of which are degenerate. Intracellular bacteria may be seen on cytology in up to 50% of cases. Protein concentration is elevated (>3 g/dL). Culture and sensitivity are positive in 60-80% of cases; aerobic and anaerobic cultures should be performed. Blood cultures are positive in 30-50% of hematogenous cases. Hematology findings include leukocytosis with a left shift, and possibly toxic neutrophils. Serum biochemistry may show hyperglobulinemia and hypoalbuminemia due to chronic inflammation. Acute phase proteins (CRP, SAA) are elevated. Coagulation panel (PT/aPTT) is recommended to rule out disseminated intravascular coagulation (DIC) in severe cases. Blood gas analysis may reveal metabolic acidosis in septic patients.

Radiography is the initial imaging modality. In early septic arthritis, radiographs may be normal or show only soft tissue swelling and joint effusion (widening of the joint space). In chronic cases (7-14 days), periarticular osteophyte formation, subchondral bone erosion, and narrowing of the joint space may be seen. In severe cases, osteomyelitis of adjacent bones may be evident. Stress radiographs are not typically used for septic arthritis but may be helpful to assess joint instability if trauma is suspected. Ultrasonography can be used to guide arthrocentesis and to assess joint effusion and synovial thickening. CT provides detailed bone assessment and is useful for detecting osteomyelitis or sequestra. MRI is superior for evaluating soft tissue structures, including synovial membrane, cartilage, and periarticular abscesses. Arthroscopy allows direct visualization of the joint, revealing synovial hyperemia, pannus, and cartilage fibrillation. Fluoroscopy may be used for intra-articular injections or drainage procedures.

Cytology of synovial fluid is critical. In septic arthritis, the fluid is highly cellular with a predominance of degenerate neutrophils. Bacteria may be seen intracellularly or extracellularly. The mucin clot is poor. Histopathology of synovial membrane, obtained via biopsy during arthrotomy or arthroscopy, shows acute and chronic inflammation with neutrophilic infiltration, synovial cell hyperplasia, and fibrin deposition. In chronic cases, fibrosis and pannus formation are seen. Special stains (Gram stain) can help identify bacterial type. If fungal infection is suspected, periodic acid-Schiff (PAS) or Gomori methenamine silver (GMS) stains are used. Histopathology is also essential to rule out neoplasia, such as synovial cell sarcoma, which may mimic septic arthritis clinically.

Treatment of septic arthritis requires a multimodal approach: antimicrobial therapy, joint lavage, and surgical debridement. Immediate stabilization of the patient is essential, including intravenous fluids for shock, and analgesia. Broad-spectrum antimicrobials should be initiated after obtaining cultures, but before results are available. Empiric therapy should cover Gram-positive and Gram-negative aerobes and anaerobes. A common protocol is ampicillin-sulbactam (22 mg/kg IV q8h) combined with enrofloxacin (10 mg/kg IV q24h) or amikacin (15-20 mg/kg IV q24h). Once culture and sensitivity results are available, antimicrobials should be adjusted to the most appropriate, least toxic, and cost-effective drug. Antimicrobial therapy should be continued for 4-6 weeks, with at least 2 weeks after clinical resolution. Joint lavage is performed to remove inflammatory debris and bacteria. This can be done via needle arthrocentesis (through large-bore needles) or through arthrotomy. In severe cases, arthrotomy with open drainage and debridement is recommended. The joint is flushed with large volumes of sterile saline (1-2 L) or balanced electrolyte solution. Surgical debridement involves removal of necrotic tissue, fibrin, and loose cartilage. In cases with extensive cartilage damage, joint resection or arthrodesis may be necessary. Postoperative management includes pain control (opioids, NSAIDs), cold therapy, and early controlled weight-bearing. Physical rehabilitation, including passive range of motion exercises and swimming, is started after 2 weeks. In cases of implant-associated infection, removal of implants may be required.

The prognosis for septic arthritis is guarded to good, depending on the severity and duration of infection, the causative organism, and the promptness of treatment. With early, aggressive therapy, the prognosis for return to function is good, especially in young animals with no pre-existing joint disease. However, even with treatment, degenerative joint disease is a common sequela. The prognosis is worse if there is significant cartilage destruction, osteomyelitis, or if the infection is caused by multidrug-resistant bacteria. Complications include chronic pain, joint stiffness, ankylosis, and recurrence of infection. Negative prognostic indicators include delayed treatment (>48 hours), presence of implants, immunocompromised patients, and severe systemic signs. The overall success rate for medical and surgical management is reported to be 70-90%, but many animals develop radiographic evidence of osteoarthritis. Functional recovery may take several months.

Postoperative follow-up is crucial. Patients are typically hospitalized for 2-5 days after surgery for IV antimicrobials and pain management. Sutures are removed 10-14 days after surgery. Serial radiographs are recommended at 4, 8, and 12 weeks to assess joint space, bone healing, and progression of osteoarthritis. Synovial fluid analysis may be repeated at 2-4 weeks to confirm resolution of infection. Restricted activity is essential for 6-8 weeks, with leash walks only. Physical therapy, including passive range of motion exercises, is started at 2 weeks and gradually increased. Swimming is encouraged after 4 weeks. Long-term monitoring includes annual radiographs to assess for osteoarthritis. Owners should be educated on signs of recurrence, such as lameness or joint swelling, and to seek immediate veterinary care if these occur.

Pearls: 1) Always perform arthrocentesis before starting antimicrobials to maximize culture yield. 2) Use a large-bore needle (18-20 gauge) for joint lavage to allow adequate flow. 3) In cases of suspected hematogenous septic arthritis, perform blood cultures and investigate for a primary source (e.g., urinary tract infection, endocarditis). 4) Consider the use of regional limb perfusion with antibiotics (e.g., amikacin) to achieve high local concentrations. 5) In chronic cases, obtain synovial membrane biopsies for histopathology and culture. Pitfalls: 1) Delaying surgical intervention in favor of medical therapy alone can lead to irreversible cartilage damage. 2) Inadequate joint lavage (using too little fluid) fails to remove debris and bacteria. 3) Using inappropriate antimicrobials (e.g., penicillin alone) without broad-spectrum coverage. 4) Failing to address underlying causes, such as osteomyelitis or foreign bodies. 5) Overlooking the possibility of fungal or mycobacterial infections in non-responsive cases.

Perioperative antimicrobial protocols: For prophylaxis in clean-contaminated joint surgery, cefazolin (22 mg/kg IV) is administered 30 minutes before incision and repeated every 90 minutes during surgery. For treatment of septic arthritis, broad-spectrum coverage is initiated: ampicillin-sulbactam (22 mg/kg IV q8h) or cefoxitin (30 mg/kg IV q8h) combined with enrofloxacin (10 mg/kg IV q24h) or amikacin (15-20 mg/kg IV q24h). Once culture results are available, narrow-spectrum antibiotics are chosen. Oral options include amoxicillin-clavulanate (13.75 mg/kg PO q12h) or clindamycin (11 mg/kg PO q12h) for anaerobes, and cephalexin (22 mg/kg PO q8h) for Gram-positives. Analgesia: Preoperative opioids such as hydromorphone (0.05-0.1 mg/kg IV) or methadone (0.1-0.2 mg/kg IV) are used. Postoperatively, a constant rate infusion (CRI) of fentanyl (2-5 μg/kg/hr) or lidocaine (25-50 μg/kg/min) may be used for 24-48 hours. NSAIDs such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) are started after surgery, but caution is needed in patients with renal compromise. Gabapentin (10-20 mg/kg PO q8-12h) can be added for neuropathic pain. Chondroprotectants such as polysulfated glycosaminoglycan (Adequan, 5 mg/kg IM q7 days for 4 weeks) may be used to support cartilage health. In cases of multidrug-resistant infections, linezolid (10 mg/kg PO q12h) or vancomycin (15 mg/kg IV q8h) may be considered, but these are reserved for severe cases.

Landmark studies in veterinary septic arthritis include: 1) A retrospective study by Bennett and Taylor (1988) on 50 dogs with septic arthritis, which found that Staphylococcus intermedius was the most common isolate and that early surgical intervention improved outcomes. 2) A study by Clements et al. (2005) comparing medical versus surgical treatment, showing that arthrotomy with lavage resulted in faster resolution and better long-term function than needle lavage alone. 3) A consensus statement from the ACVS (2015) on antimicrobial use in orthopedic surgery, recommending perioperative antibiotics for joint surgery and emphasizing the importance of culture-guided therapy. 4) A study by Hmam et al. (2019) on regional limb perfusion with amikacin in dogs with septic arthritis, demonstrating high synovial fluid concentrations and improved outcomes. 5) A meta-analysis by Fahie and Smith (2018) on prognostic factors, identifying duration of clinical signs and presence of osteomyelitis as negative predictors. These studies underscore the importance of prompt, aggressive surgical and medical management to preserve joint function and prevent systemic complications.